Fee-for-value in the pharmaceutical industry: a policy framework applying data science to negotiate drug prices

DSpace/Manakin Repository

Fee-for-value in the pharmaceutical industry: a policy framework applying data science to negotiate drug prices

Citable link to this page

 

 
Title: Fee-for-value in the pharmaceutical industry: a policy framework applying data science to negotiate drug prices
Author: Patel, Nisarg A.
Citation: Patel, Nisarg A. 2017. “Fee-for-value in the pharmaceutical industry: a policy framework applying data science to negotiate drug prices.” Journal of Law and the Biosciences 4 (1): 205-215. doi:10.1093/jlb/lsx002. http://dx.doi.org/10.1093/jlb/lsx002.
Full Text & Related Files:
Abstract:
Published Version: doi:10.1093/jlb/lsx002
Other Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5570706/pdf/
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:34375195
Downloads of this work:

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters